There are multiple treatment modalities for acromegaly and the current consensus on the treatment goals include normalization of IGF-1 levels, reduction of GH levels below 1.0 ug/L, decrease of tumour volume, and improvement of clinical signs and symptoms ( 5 , 6 ). The gene discussed is IGF1; the disease is acromegaly.